TipRanks
DBV Technologies SA - American (DBVT)
NASDAQ:DBVT
US Market
DBVT
DBV Technologies SA - American
RESEARCH TOOLSreports
Want to see DBVT full AI Analyst Report?

DBV Technologies SA - American (DBVT) Stock Forecast & Price Target

461 Followers
See the Price Targets and Ratings of:

DBVT Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
Based on 2 analysts giving stock ratings to
DBV
Technologies SA - American
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DBVT Stock 12 Month Forecast

Average Price Target

$42.50
▲(183.90% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for DBV Technologies SA - American in the last 3 months. The average price target is $42.50 with a high forecast of $45.00 and a low forecast of $40.00. The average price target represents a 183.90% change from the last price of $14.97.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","46":"$46","18.25":"$18.25","27.5":"$27.5","36.75":"$36.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$45.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":42.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$42.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,18.25,27.5,36.75,46],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.21,13.80923076923077,16.408461538461538,19.00769230769231,21.606923076923078,24.206153846153846,26.805384615384618,29.404615384615386,32.003846153846155,34.60307692307693,37.20230769230769,39.80153846153846,42.40076923076923,{"y":45,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.21,13.616923076923078,16.023846153846154,18.43076923076923,20.837692307692308,23.244615384615386,25.65153846153846,28.058461538461536,30.465384615384615,32.87230769230769,35.279230769230765,37.68615384615384,40.09307692307692,{"y":42.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.21,13.424615384615386,15.639230769230771,17.853846153846156,20.06846153846154,22.283076923076926,24.497692307692308,26.712307692307693,28.926923076923078,31.141538461538463,33.356153846153845,35.57076923076923,37.785384615384615,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.07,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.64,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.98,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.17,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.59,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.25,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.5,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.87,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.8,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.73,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.5,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.42,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.21,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$45.00Average Price Target$42.50Lowest Price Target$40.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
LifeSci Capital Analyst forecast on DBVT
Sam Slutsky
LifeSci Capital
LifeSci Capital
$45
Buy
200.60%
Upside
Reiterated
09/30/26
DBV Technologies: Viaskin Peanut’s Strong Pediatric Prospects and Unchanged $45 Price Target Support Buy Rating
H.C. Wainwright Analyst forecast on DBVT
Andrew Fein
H.C. Wainwright
H.C. Wainwright
$40
Buy
167.20%
Upside
Reiterated
09/21/26
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA - American (NASDAQ: DBVT) and TransMedics Group (NASDAQ: TMDX)
Guggenheim Analyst forecast on DBVT
Yatin Suneja
Guggenheim
Guggenheim
$51
Buy
240.68%
Upside
Reiterated
07/17/26
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA - American (NASDAQ: DBVT), Intuitive Surgical (NASDAQ: ISRG) and Staar Surgical (NASDAQ: STAA)
Cantor Fitzgerald Analyst forecast on DBVT
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
$48
Buy
220.64%
Upside
Reiterated
07/16/26
Cantor Fitzgerald Keeps Their Buy Rating on DBV Technologies SA - American (DBVT)
Citizens JMP Analyst forecast on DBVT
Jonathan Wolleben
Citizens JMP
Citizens JMP
$55
Buy
267.40%
Upside
Reiterated
06/30/26
DBV Technologies delays Viaskin BLA submission to Q3, says CitizensDBV Technologies delays Viaskin BLA submission to Q3, says Citizens
Goldman Sachs Analyst forecast on DBVT
Rajan Sharma
Goldman Sachs
Goldman Sachs
$7.94→$5.81
Sell
-61.19%
Downside
Reiterated
04/09/26
Goldman Sachs Keeps Their Sell Rating on DBV Technologies SA - American (DBVT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
LifeSci Capital Analyst forecast on DBVT
Sam Slutsky
LifeSci Capital
LifeSci Capital
$45
Buy
200.60%
Upside
Reiterated
09/30/26
DBV Technologies: Viaskin Peanut’s Strong Pediatric Prospects and Unchanged $45 Price Target Support Buy Rating
H.C. Wainwright Analyst forecast on DBVT
Andrew Fein
H.C. Wainwright
H.C. Wainwright
$40
Buy
167.20%
Upside
Reiterated
09/21/26
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA - American (NASDAQ: DBVT) and TransMedics Group (NASDAQ: TMDX)
Guggenheim Analyst forecast on DBVT
Yatin Suneja
Guggenheim
Guggenheim
$51
Buy
240.68%
Upside
Reiterated
07/17/26
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA - American (NASDAQ: DBVT), Intuitive Surgical (NASDAQ: ISRG) and Staar Surgical (NASDAQ: STAA)
Cantor Fitzgerald Analyst forecast on DBVT
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
$48
Buy
220.64%
Upside
Reiterated
07/16/26
Cantor Fitzgerald Keeps Their Buy Rating on DBV Technologies SA - American (DBVT)
Citizens JMP Analyst forecast on DBVT
Jonathan Wolleben
Citizens JMP
Citizens JMP
$55
Buy
267.40%
Upside
Reiterated
06/30/26
DBV Technologies delays Viaskin BLA submission to Q3, says CitizensDBV Technologies delays Viaskin BLA submission to Q3, says Citizens
Goldman Sachs Analyst forecast on DBVT
Rajan Sharma
Goldman Sachs
Goldman Sachs
$7.94→$5.81
Sell
-61.19%
Downside
Reiterated
04/09/26
Goldman Sachs Keeps Their Sell Rating on DBV Technologies SA - American (DBVT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DBV Technologies SA - American

3 Months
Jonathan WollebenCitizens JMP
Success Rate
10/26 ratings generated profit
38%
Average Return
+4.08%
Copying Jonathan Wolleben's trades and holding each position for 3 Months would result in 38.46% of your transactions generating a profit, with an average return of +4.08% per trade.
1 Year
Jonathan WollebenCitizens JMP
Success Rate
11/26 ratings generated profit
42%
Average Return
+48.53%
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 42.31% of your transactions generating a profit, with an average return of +48.53% per trade.
2 Years
Jonathan WollebenCitizens JMP
Success Rate
11/26 ratings generated profit
42%
Average Return
+32.97%
Copying Jonathan Wolleben's trades and holding each position for 2 Years would result in 42.31% of your transactions generating a profit, with an average return of +32.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DBVT Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
12
12
9
6
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
1
0
0
0
0
total
13
12
9
6
2
In the current month, DBVT has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DBVT average Analyst price target in the past 3 months is 42.50.
Each month's total comprises the sum of three months' worth of ratings.

DBVT Financial Forecast

DBVT Earnings Forecast

Next quarter’s earnings estimate for DBVT is -$0.14 with a range of -$0.26 to -$0.09. The previous quarter’s EPS was -$0.12. DBVT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DBVT has Performed in-line its overall industry.
Next quarter’s earnings estimate for DBVT is -$0.14 with a range of -$0.26 to -$0.09. The previous quarter’s EPS was -$0.12. DBVT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DBVT has Performed in-line its overall industry.
No data currently available

DBVT Sales Forecast

Next quarter’s sales forecast for DBVT is $664.00K with a range of $0.00 to $1.00M. The previous quarter’s sales results were $0.00. DBVT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DBVT has Performed in-line its overall industry.
Next quarter’s sales forecast for DBVT is $664.00K with a range of $0.00 to $1.00M. The previous quarter’s sales results were $0.00. DBVT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DBVT has Performed in-line its overall industry.

DBVT Stock Forecast FAQ

What is DBVT’s average 12-month price target, according to analysts?
Based on analyst ratings, DBV Technologies SA - American’s 12-month average price target is 42.50.
    What is DBVT’s upside potential, based on the analysts’ average price target?
    DBV Technologies SA - American has 183.90% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DBVT a Buy, Sell or Hold?
          DBV Technologies SA - American has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
            What is DBV Technologies SA - American’s price target?
            The average price target for DBV Technologies SA - American is 42.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $45.00 ,the lowest forecast is $40.00. The average price target represents 183.90% Increase from the current price of $14.97.
              What do analysts say about DBV Technologies SA - American?
              DBV Technologies SA - American’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of DBVT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.